The Student Room Group

P450 Inducers vs Inhibitors, what do they actually do?

Hello, I hope you wont mind clarifying this for me please

P450 inducers stimulate metabolism, say for example they are co-administered with warfarin, does this mean that they will make warfarin less potent and increase the risk of DVT?

have I understood this wrong?

Thank you
(edited 8 years ago)
Original post by Cannula
Hello, I hope you wont mind clarifying this for me please

P450 inducers stimulate metabolism, say for example they are co-administered with warfarin, does this mean that they will make warfarin less potent and increase the risk of DVT?

have I understood this wrong?

Thank you


Inducer, e.g. rifampicin = a drug that stimulates the production of a CYP450 enzyme, e.g. CYP2C19. If a drug, e.g. warfarin is metabolised (into an inactive compound) by this enzyme, then warfarin will be metabolised more quickly under the influence of rifampicin. This means that the plasma concentration of warfarin will decrease, meaning that the INR will decrease (as the anticoagulant effect of warfarin is lessened). This will mean that the patient will be at an increased risk of DVT, PE etc. The easiest thing to do would probably be to increase the dose of warfarin whilst the patient is on rifampicin (dose according to INR) and keep a close eye on the INR and potential side effects of warfarin, like haemorrhage.

An inhibitor of the enzyme, e.g. erythromycin, will inhibit the production of the enzyme CYP2C19, meaning that warfarin will be metabolised very slowly, so its plasma concentration will increase with successive dosing, and hence the INR will increase. This will lead to an increased risk of side effects, e.g. haemorrhage. The best thing to do, again, would be to dose the warfarin according to INR, if this antibiotic is essential - if not, try and find a suitable alternative that won't interact with warfarin.*

Another example: a patient is on simvastatin, and drinks a glass of grapefruit juice with breakfast every morning. He starts to get muscle pains (without any obvious causes). Why?

Spoiler



It's also important to know that some drugs are activated by CYP450 enzymes too, e.g. codeine (into morphine), and clopidogrel. Therefore, if you inhibit the enzyme that metabolises them, you will decrease the plasma concentration of the active compound, and thus not get enough pain relief or enough antiplatelet effect. If you induce the enzyme that metabolises them, you will increase the plasma concentration of the active compound, and thus risk the onset of systemic side/toxic effects.

I'd say CYP2C19, 2D6 and 3A4 are good CYP450 isoenzymes to remember. It's probably good to also know a few common examples of inducers, e.g. phenytoin and rifampicin; and inhibitors, e.g. erythromycin, cimetidine (although rarely used now)

* EDIT: Antibiotics are probably a bad example to use here as all orally-administered antibiotics interact with warfarin - they can destroy gut flora, which are responsible for the absorption of very lipophilic drugs like warfarin through enterohepatic circulation.

Hope this helps!
(edited 8 years ago)
Original post by Cannula
Hello, I hope you wont mind clarifying this for me please

P450 inducers stimulate metabolism, say for example they are co-administered with warfarin, does this mean that they will make warfarin less potent and increase the risk of DVT?


Yes
Reply 3
Original post by thegodofgod
Inducer, e.g. rifampicin = a drug that stimulates the production of a CYP450 enzyme, e.g. CYP2C19. If a drug, e.g. warfarin is metabolised (into an inactive compound) by this enzyme, then warfarin will be metabolised more quickly under the influence of rifampicin. This means that the plasma concentration of warfarin will decrease, meaning that the INR will decrease (as the anticoagulant effect of warfarin is lessened). This will mean that the patient will be at an increased risk of DVT, PE etc. The easiest thing to do would probably be to increase the dose of warfarin whilst the patient is on rifampicin (dose according to INR) and keep a close eye on the INR and potential side effects of warfarin, like haemorrhage.

An inhibitor of the enzyme, e.g. erythromycin, will inhibit the production of the enzyme CYP2C19, meaning that warfarin will be metabolised very slowly, so its plasma concentration will increase with successive dosing, and hence the INR will increase. This will lead to an increased risk of side effects, e.g. haemorrhage. The best thing to do, again, would be to dose the warfarin according to INR, if this antibiotic is essential - if not, try and find a suitable alternative that won't interact with warfarin.*

Another example: a patient is on simvastatin, and drinks a glass of grapefruit juice with breakfast every morning. He starts to get muscle pains (without any obvious causes). Why?

Spoiler


It's also important to know that some drugs are activated by CYP450 enzymes too, e.g. codeine (into morphine), and clopidogrel. Therefore, if you inhibit the enzyme that metabolises them, you will decrease the plasma concentration of the active compound, and thus not get enough pain relief or enough antiplatelet effect. If you induce the enzyme that metabolises them, you will increase the plasma concentration of the active compound, and thus risk the onset of systemic side/toxic effects.

I'd say CYP2C19, 2D6 and 3A4 are good CYP450 isoenzymes to remember. It's probably good to also know a few common examples of inducers, e.g. phenytoin and rifampicin; and inhibitors, e.g. erythromycin, cimetidine (although rarely used now)

* EDIT: Antibiotics are probably a bad example to use here as all orally-administered antibiotics interact with warfarin - they can destroy gut flora, which are responsible for the absorption of very lipophilic drugs like warfarin through enterohepatic circulation.

Hope this helps!



Awesome explanation, this should be put on wiki! Thanks!
Original post by thegodofgod
Hope this helps!


Posts like this make me very glad pharmacists exist and I don't have to remember it all.
Original post by Cannula
Awesome explanation, this should be put on wiki! Thanks!


Glad to see it was useful! :smile:

About 90% of drugs are metabolised via CYP450 isoenzymes, and many of them are inducers and inhibitors of the same enzymes, so it's really important to know common drugs that can lead to pharmacokinetic interactions. These types of interactions are often overlooked as pharmacodynamic interactions are the major ones that you think of first, most likely because they're very logical, e.g. prescribing an agonist and antagonist at the same receptor. Pharmacokinetic interactions you kind of just have to know; both are a major part of safe prescribing.

Original post by Hype en Ecosse
Posts like this make me very glad pharmacists exist and I don't have to remember it all.


Haha! I was at a placement earlier this year shadowing a prescribing hospital pharmacist who ran her own anticoagulation clinic (mainly to do with counselling newly warfarinised patients and those on other anticoagulants), and she was absolutely on point when it came to drug interactions with warfarin - not just the names of the drugs, but also the nature of the interaction, which I found quite awesome to be honest :biggrin:

Quick Reply

Latest

Trending

Trending